A detailed history of Everhart Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Everhart Financial Group, Inc. holds 5,433 shares of LLY stock, worth $4.29 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
5,433
Previous 4,761 14.11%
Holding current value
$4.29 Million
Previous $4.31 Million 11.67%
% of portfolio
1.08%
Previous 1.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $518,878 - $645,133
672 Added 14.11%
5,433 $4.81 Million
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $337,064 - $422,703
465 Added 10.82%
4,761 $4.31 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $254,053 - $339,888
429 Added 11.09%
4,296 $3.34 Million
Q4 2023

Jan 12, 2024

BUY
$525.19 - $619.13 $136,549 - $160,973
260 Added 7.21%
3,867 $2.25 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $104,328 - $143,832
240 Added 7.13%
3,607 $1.94 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $76,812 - $102,706
219 Added 6.96%
3,367 $1.58 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $46,594 - $54,723
150 Added 5.0%
3,148 $1.08 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $83,281 - $97,039
259 Added 9.46%
2,998 $1.1 Million
Q3 2022

Oct 12, 2022

BUY
$296.48 - $337.87 $81,532 - $92,914
275 Added 11.16%
2,739 $886,000
Q2 2022

Jul 12, 2022

BUY
$278.73 - $327.27 $152,465 - $179,016
547 Added 28.53%
2,464 $799,000
Q1 2022

Apr 18, 2022

BUY
$234.69 - $291.66 $154,191 - $191,620
657 Added 52.14%
1,917 $549,000
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $283,311 - $351,590
1,260 New
1,260 $348,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Everhart Financial Group, Inc. Portfolio

Follow Everhart Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everhart Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Everhart Financial Group, Inc. with notifications on news.